Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 16/20 | 0.44 |
| ▸ | SSTR1 | P30872 | 3/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4527979 | 0.92 | SSTR4 (0.46) | SSTR4SSTR1TRPV1 | |
| SCHEMBL27853596 | 0.83 | SSTR4 (0.43) | SSTR4SSTR1 | |
| SCHEMBL5709212 | 0.83 | TRPV1 (0.43) | SSTR4SSTR1TRPV1 | |
| SCHEMBL27725726 | 0.81 | SSTR4 (0.43) | SSTR4SSTR1 | |
| SCHEMBL4537897 | 0.80 | L3MBTL1 (0.43) | SSTR4 | |
| SCHEMBL20797342 | 0.80 | SSTR4 (0.46) | SSTR4SSTR1 | |
| SCHEMBL5709016 | 0.79 | SLC22A12 (0.47) | SSTR4SSTR1 | |
| SCHEMBL4947195 | 0.78 | SSTR4 (0.44) | SSTR4SSTR1TRPV1 | |
| SCHEMBL2635568 | 0.78 | KIF11 (0.42) | SSTR4SSTR1TRPV1 | |
| SCHEMBL4538158 | 0.77 | MAPK8 (0.43) | SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8258136-B2 | Pyridazine compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20090275589-A1 | Pyridazine Compound and Use Thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-11-05 | — | — | US | disclosed |
| EP-1958946-A1 | PYRIDAZINE COMPOUND AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2008-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275589-A1 | Pyridazine Compound and Use Thereof | PLPBP, PNPO, PDXK | SSTR4 4327/4885SSTR1 4348/4885TRPV1 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.